Literature DB >> 3876271

Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.

K Kuribayashi, A Keyaki, S Sakaguchi, T Masuda.   

Abstract

A CTL line (CTLL-D4) mediating specific cytolytic activity against radiation-induced leukaemia RL male 1 has been established and maintained on a long-term basis without the addition of exogeneous TCGF. This line was originally selected by the limiting dilution of MLTC cells from RL male 1-immune (BALB/c X C57BL/6) F1-nu/+(CB6F1-nu/+) spleen cells (500 cells/well) in the presence of 5% rat TCGF, 2000 rads-irradiated normal CB6F1-nu/+ spleen cells as the feeder cells, and 10,000 rads-irradiated RL male 1 tumour cells as the stimulator. After expansion only with the feeder and tumour cells, CTLL-D4 shows highly specific cytotoxic activity against RL male 1 by in vitro CMC assay, since cells such as RL male 6, RL female 8, RL female 9, P815, MOPC-315 (H-2d), EL-4 (H-2b) and YAC (H-2a) are not killed. Microcytoxicity assay of this line has revealed that CTLL-D4 comprises three subsets of T lymphocytes (100% Thy-1.2+): 15-25% Lyt-1+23-, 60-75% Lyt-1+23+ and 10-15% Lyt-1-23+. The proliferation of this line seems to depend largely upon the syngeneic MLR-like responsiveness of the Lyt-1+23- subsets of CTLL-D4 to the Ia-positive cells in CB6F1-nu/+ splenic feeder cells, and has been restricted to the H-2d-haplotype of the feeder cells. In spite of the vigorous cell proliferation by coculturing with the feeder cells alone, the cytolytic activity of this line begins to decrease after some 7 days of culture in the absence of the stimulator RL male 1 cells which have no capacity to stimulate by themselves. Thus, by long-term culture of CTLL-D4 with the syngeneic feeder cells alone, a new non-cytolytic line (D4f) was established. Mechanisms enabling the long-term maintenance of CTL activity and subset composition have been discussed in terms of cellular cooperation between the subsets of this line.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876271      PMCID: PMC1453654     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

Review 2.  The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.

Authors:  E Kedar; D W Weiss
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

Review 3.  Which T cells cause graft rejection?

Authors:  B E Loveland; I F McKenzie
Journal:  Transplantation       Date:  1982-03       Impact factor: 4.939

Review 4.  The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses.

Authors:  J J Farrar; W R Benjamin; M L Hilfiker; M Howard; W L Farrar; J Fuller-Farrar
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.

Authors:  A Keyaki; K Kuribayashi; S Sakaguchi; T Masuda; J Yamashita; H Handa; E Nakayama
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

6.  Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.

Authors:  R H Carter; J A Drebin; S Schatten; L L Perry; M I Greene
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells.

Authors:  H D Engers; G D Sorenson; G Terres; C Horvath; K T Brunner
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

8.  Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.

Authors:  C D Mills; R J North
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

9.  Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.

Authors:  S Sakaguchi; T Takahashi; Y Nishizuka
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

10.  Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.

Authors:  H Sato; E A Boyse; T Aoki; C Iritani; L J Old
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  2 in total

1.  Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.

Authors:  T Kitajima; M Iwashiro; K Kuribayashi; S Imamura
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

2.  Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.

Authors:  A Keyaki; K Kuribayashi; S Sakaguchi; T Masuda; J Yamashita; H Handa; E Nakayama
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.